US Patent 8791244 Anti-ErbB3 antibodies and uses thereof
Patent 8791244 was granted and assigned to Regeneron Pharmaceuticals, Inc. on July, 2014 by the United States Patent and Trademark Office.
All edits
Edits on 11 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 4 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08791244 Anti-ErbB3 antibodies and uses thereof US Patent 8791244 Anti-ErbB3 antibodies and uses thereof
Infobox
Patent Number
0879124400
Patent Number
879124400
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 27 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
0
Current Assignee
0
Patent Jurisdiction
Patent Number
087912440
Date of Patent
July 29, 2014
0Patent Application Number
136238850
Date Filed
September 21, 2012
0Official Website
Patent Primary Examiner
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
0
Current Assignee
0
Patent Jurisdiction
Patent Number
087912440
Date of Patent
July 29, 2014
0Patent Application Number
136238850
Date Filed
September 21, 2012
0Official Website
Patent Primary Examiner
Edits on 19 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 24 Dec, 2021
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 08791244 Anti-ErbB3 antibodies and uses thereof
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
08791244
Date of patent
July 29, 2014
Patent application number
13623885
Date Filed
September 21, 2012
Patent primary examiner
Find more entities like US Patent 8791244 Anti-ErbB3 antibodies and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
